Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nate Aiken

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Total Gleason Pattern 4 Length Outperforms Grade Group and Clinical Models in Predicting Oncologic Outcomes in Grade Group 2-4 Prostate CancerNicholas A Pickersgill, Sean A Fletcher, Nate Aiken, et al.
Gynecologic Oncology|July 29, 2020
Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot studyOliver Zivanovic, Ling Y Chen, Andrew Vickers, et al.
Diseases of the Colon and Rectum|September 14, 2022
Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality TherapyJames P Taylor, Iris H Wei, J Joshua Smith, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Total Gleason Pattern 4 Length Outperforms Grade Group and Clinical Models in Predicting Oncologic Outcomes in Grade Group 2-4 Prostate CancerNicholas A Pickersgill, Sean A Fletcher, Nate Aiken, et al.
Gynecologic Oncology|July 29, 2020
Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot studyOliver Zivanovic, Ling Y Chen, Andrew Vickers, et al.
Diseases of the Colon and Rectum|September 14, 2022
Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality TherapyJames P Taylor, Iris H Wei, J Joshua Smith, et al.
Pageof 1